Literature DB >> 9427059

Failure of PCT to indicate severe fungal infection in two immunodeficient patients.

W Huber, U Schweigart, P Bottermann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9427059     DOI： 10.1007/bf01740823

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  5 in total

1.  High serum procalcitonin level in a 4-year-old liver transplant recipient with a disseminated candidiasis.

Authors:  Y Gérard; D Hober; S Petitjean; M Assicot; C Bohuon; Y Mouton; P Wattré
Journal:  Infection       Date:  1995 Sep-Oct       Impact factor: 3.553

2.  High serum procalcitonin concentrations in patients with sepsis and infection.

Authors:  M Assicot; D Gendrel; H Carsin; J Raymond; J Guilbaud; C Bohuon
Journal:  Lancet       Date:  1993-02-27       Impact factor: 79.321

3.  Procalcitonin in diagnosis of severe infections.

Authors:  B Al-Nawas; I Krammer; P M Shah
Journal:  Eur J Med Res       Date:  1996-04-18       Impact factor: 2.175

4.  The complete sequence of human preprocalcitonin.

Authors:  J M Le Moullec; A Jullienne; J Chenais; F Lasmoles; J M Guliana; G Milhaud; M S Moukhtar
Journal:  FEBS Lett       Date:  1984-02-13       Impact factor: 4.124

5.  Procalcitonin, a marker of bacterial infection.

Authors:  D Gendrel; C Bohuon
Journal:  Infection       Date:  1997 May-Jun       Impact factor: 3.553
  5 in total
  10 in total

1.  Value of measuring serum procalcitonin, C-reactive protein, and mannan antigens to distinguish fungal from bacterial infections.

Authors:  G L Petrikkos; S A Christofilopoulou; N K Tentolouris; E A Charvalos; C J Kosmidis; G L Daikos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-04       Impact factor: 3.267

2.  Serum procalcitonin measurement contribution to the early diagnosis of candidemia in critically ill patients.

Authors:  Pierre Emmanuel Charles; Frédéric Dalle; Serge Aho; Jean-Pierre Quenot; Jean-Marc Doise; Hervé Aube; Nils-Olivier Olsson; Bernard Blettery
Journal:  Intensive Care Med       Date:  2006-08-08       Impact factor: 17.440

3.  Procalcitonin--a marker of invasive fungal infection?

Authors:  H J Dornbusch; V Strenger; R Kerbl; H Lackner; W Schwinger; P Sovinz; C Urban
Journal:  Support Care Cancer       Date:  2005-01-19       Impact factor: 3.603

Review 4.  [Procalcitonin-based algorithm. Management of antibiotic therapy in critically ill patients].

Authors:  M Hochreiter; S Schroeder
Journal:  Anaesthesist       Date:  2011-07       Impact factor: 1.041

5.  The role of procalcitonin in neonatal intensive care unit patients with candidemia.

Authors:  Maria Teresa Montagna; Caterina Coretti; Antonella Rella; Giovanna Barbuti; Fabio Manca; Osvaldo Montagna; Nicola Laforgia; Giuseppina Caggiano
Journal:  Folia Microbiol (Praha)       Date:  2012-06-12       Impact factor: 2.099

6.  New approaches to sepsis: molecular diagnostics and biomarkers.

Authors:  Konrad Reinhart; Michael Bauer; Niels C Riedemann; Christiane S Hartog
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

Review 7.  [Diagnostic markers and assessment of efficacy of antibacterial therapy].

Authors:  K-F Bodmann
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-04-05       Impact factor: 0.840

8.  Serum procalcitonin in viral and bacterial meningitis.

Authors:  Usama M Alkholi; Nermin Abd Al-Monem; Ayman A Abd El-Azim; Mohamed H Sultan
Journal:  J Glob Infect Dis       Date:  2011-01

9.  Monitoring procalcitonin in febrile neutropenia: what is its utility for initial diagnosis of infection and reassessment in persistent fever?

Authors:  James Owen Robinson; Frédéric Lamoth; Frank Bally; Marlies Knaup; Thierry Calandra; Oscar Marchetti
Journal:  PLoS One       Date:  2011-04-25       Impact factor: 3.240

10.  Serum procalcitonin and cerebrospinal fluid cytokines level in children with meningitis.

Authors:  Erdal Taskin; Mehmet Turgut; Mehmet Kilic; Handan Akbulut; A Denizmen Aygun
Journal:  Mediators Inflamm       Date:  2004-08       Impact factor: 4.711
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.